Holen Sie sich die Stockscreener-App
1.19
0.42%
0.01
Handel nachbörslich:
1.17
-0.02
-1.68%
Schlusskurs vom Vortag:
$1.18
Offen:
$1.18
24-Stunden-Volumen:
752.21K
Relative Volume:
0.63
Marktkapitalisierung:
$163.30M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1019
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
+12.86%
1M Leistung:
+15.05%
6M Leistung:
-0.42%
1J Leistung:
+52.04%
1-Tages-Spanne:
$1.15
$1.21
1-Wochen-Bereich:
$1.055
$1.2699
52-Wochen-Spanne:
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.19 | 120.23M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
What earnings revisions data tells us about Lucid Diagnostics Inc.2025 Support & Resistance & Stock Market Timing Techniques - newser.com
Is Lucid Diagnostics Inc. trending in predictive chart modelsWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
What MACD and RSI say about Lucid Diagnostics Inc.July 2025 Levels & Weekly High Return Opportunities - newser.com
Can Lucid Diagnostics Inc. stock sustain revenue growthDividend Hike & Free High Return Stock Watch Alerts - newser.com
Understanding Lucid Diagnostics Inc.’s price movementMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervaluedJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Using flow based indicators on Lucid Diagnostics Inc.Trade Volume Summary & High Win Rate Trade Alerts - newser.com
Lucid Diagnostics Inc Stock Analysis and ForecastTechnical Breakout Signals & Double Digit Wealth Tips - earlytimes.in
Can Lucid Diagnostics Inc. recover in the next quarterWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
How sentiment analysis helps forecast Lucid Diagnostics Inc.Portfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com
Earnings visualization tools for Lucid Diagnostics Inc.Weekly Market Summary & Fast Entry High Yield Tips - newser.com
PAVmed subsidiary Veris Health launches cancer care platform at OSU center - Investing.com Canada
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $8.00 - MarketBeat
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Ascendiant Capital Raises Price Target for Lucid Diagnostics (LU - GuruFocus
Will Lucid Diagnostics Inc. stock benefit from automationMarket Weekly Review & Verified Chart Pattern Trade Signals - newser.com
Can Lucid Diagnostics Inc. stock beat analyst upgradesWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Lucid Diagnostics (NASDAQ:LUCD) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
What sentiment indicators say about Lucid Diagnostics Inc. stockJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
What recovery options are there for Lucid Diagnostics Inc.Weekly Market Report & Reliable Price Breakout Signals - newser.com
Reversal indicators forming on Lucid Diagnostics Inc. stockInsider Selling & Consistent Profit Alerts - newser.com
Will a bounce in Lucid Diagnostics Inc. offer an exit2025 Top Gainers & Trade Opportunity Analysis - newser.com
Identifying reversal signals in Lucid Diagnostics Inc.Earnings Trend Report & Daily Technical Forecast Reports - newser.com
Tick level data insight on Lucid Diagnostics Inc. volatilityTrade Performance Summary & AI Driven Stock Reports - newser.com
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) PT at $3.65 - Defense World
Altoona firefighters receive cancer screenings - WJAC
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Published on: 2025-09-29 09:04:08 - newser.com
Lucid Diagnostics: Holding Onto Medicare Coverage Hopes (NASDAQ:LUCD) - Seeking Alpha
Published on: 2025-09-29 01:30:08 - newser.com
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lucid Diagnostics Inc-Aktie (LUCD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):